Compare $LNTH vs $MDLN | Chartloom

Compare

$LNTH vs $MDLN

Lantheus Holdings Inc · Medline Inc

LNTH

Lantheus Holdings Inc

MDLN

Medline Inc

Compare $LNTH vs $MDLN

Comparing Lantheus Holdings Inc and Medline Inc

LNTHLantheus Holdings Inc

MDLNMedline Inc

LNTHLantheus Holdings Inc

Market cap

$6.52B

P/E (TTM)

24.56x

Forward P/E (NTM)

17.43x

Forward P/S (NTM)

4.16x

Rev growth (TTM)

2.3%

YTD performance

48.9%

52W performance

87.0%

FCF yield

5.9%

MDLNMedline Inc

Market cap

$47.63B

P/E (TTM)

44.92x

Forward P/E (NTM)

24.12x

Forward P/S (NTM)

1.44x

Rev growth (TTM)

—

YTD performance

-10.7%

52W performance

-11.6%

FCF yield

3.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LNTH

MDLN

Detailed metrics comparison

LNTH

Lantheus Holdings Inc

MDLN

Medline Inc

Market Cap

LNTH$6.52B

MDLN$47.63B

Enterprise Value

LNTH$6.50B

MDLN$57.88B

Price

LNTH$100.15

MDLN$36.26

P/E Ratio

LNTH24.56x

MDLN44.92x

P/S Ratio

LNTH4.19x

MDLN1.59x

EV/Sales

LNTH4.18x

MDLN1.93x

EV/EBITDA

LNTH15.80x

MDLN17.66x

P/B Ratio

LNTH4.98x

MDLN4.05x

P/FCF Ratio

LNTH16.81x

MDLN30.81x

EV/FCF

LNTH16.76x

MDLN37.44x

PEG Ratio

LNTH2.43x

MDLN3.82x

Forward P/E (NTM)

LNTH17.43x

MDLN24.12x

Forward P/S (NTM)

LNTH4.16x

MDLN1.44x

Revenue (TTM)

LNTH$1.56B

MDLN$29.94B

Revenue Growth (YoY)

LNTH2.3%

MDLNN/A

Forward Rev Growth

LNTH11.8%

MDLN7.8%

Gross Margin (TTM)

LNTH61.0%

MDLN26.2%

Operating Margin (TTM)

LNTH23.3%

MDLN6.0%

EBITDA Margin (TTM)

LNTH25.9%

MDLN10.9%

Net Margin (TTM)

LNTH17.7%

MDLN2.3%

FCF Margin (TTM)

LNTH24.9%

MDLN5.2%

Net Income (TTM)

LNTH$275M

MDLN$695M

FCF (TTM)

LNTH$388M

MDLN$1.55B

EPS (TTM)

LNTH$4.08

MDLN$0.81

ROE (TTM)

LNTH23.3%

MDLN5.5%

ROA (TTM)

LNTH11.9%

MDLN1.8%

ROIC (TTM)

LNTH15.7%

MDLN2.6%

Cash

LNTH$593M

MDLN$2.33B

Debt

LNTH$571M

MDLN$12.58B

Net Cash/Debt

LNTH$22M

MDLN$-10.25B

Current Ratio (TTM)

LNTH3.06x

MDLN4.33x

Quick Ratio (TTM)

LNTH2.89x

MDLN2.61x

Debt/Equity (TTM)

LNTH0.44x

MDLN1.09x

Debt/Assets (TTM)

LNTH0.0%

MDLN0.0%

Interest Coverage (TTM)

LNTHN/A

MDLNN/A

Net Debt/EBITDA (TTM)

LNTH0.00x

MDLN0.00x

Beta

LNTH0.04

MDLN0.94

52W Performance

LNTH87.0%

MDLN-11.6%

YTD Performance

LNTH48.9%

MDLN-10.7%

% from 52W High

LNTH-10.5%

MDLN-28.7%

% from 52W Low

LNTH99.7%

MDLN15.1%

Asset Turnover (TTM)

LNTH0.67x

MDLN0.78x

FCF Yield (TTM)

LNTH5.9%

MDLN3.2%

Earnings Yield (TTM)

LNTH4.2%

MDLN1.5%

Dividend Yield (TTM)

LNTHN/A

MDLNN/A

Rule of 40

LNTH27.3

MDLN5.2

EV/GP/RG

LNTH11.23

MDLN0.72

Ticker research

View LNTH research View MDLN research

Metric	LNTH Lantheus Holdings Inc	MDLN Medline Inc
Market & Valuation
Market Cap	$6.52B	$47.63B
Enterprise Value	$6.50B	$57.88B
Price	$100.15	$36.26
P/E Ratio	24.56x	44.92x
P/S Ratio	4.19x	1.59x
EV/Sales	4.18x	1.93x
EV/EBITDA	15.80x	17.66x
P/B Ratio	4.98x	4.05x
P/FCF Ratio	16.81x	30.81x
EV/FCF	16.76x	37.44x
PEG Ratio	2.43x	3.82x
Forward P/E (NTM)	17.43x	24.12x
Forward P/S (NTM)	4.16x	1.44x
Revenue & Growth
Revenue (TTM)	$1.56B	$29.94B
Revenue Growth (YoY)	2.3%	N/A
Forward Rev Growth	11.8%	7.8%
Profitability
Gross Margin (TTM)	61.0%	26.2%
Operating Margin (TTM)	23.3%	6.0%
EBITDA Margin (TTM)	25.9%	10.9%
Net Margin (TTM)	17.7%	2.3%
FCF Margin (TTM)	24.9%	5.2%
Net Income (TTM)	$275M	$695M
FCF (TTM)	$388M	$1.55B
EPS (TTM)	$4.08	$0.81
ROE (TTM)	23.3%	5.5%
ROA (TTM)	11.9%	1.8%
ROIC (TTM)	15.7%	2.6%
Financial Health
Cash	$593M	$2.33B
Debt	$571M	$12.58B
Net Cash/Debt	$22M	$-10.25B
Current Ratio (TTM)	3.06x	4.33x
Quick Ratio (TTM)	2.89x	2.61x
Debt/Equity (TTM)	0.44x	1.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	0.94
52W Performance	87.0%	-11.6%
YTD Performance	48.9%	-10.7%
% from 52W High	-10.5%	-28.7%
% from 52W Low	99.7%	15.1%
Efficiency & Yields
Asset Turnover (TTM)	0.67x	0.78x
FCF Yield (TTM)	5.9%	3.2%
Earnings Yield (TTM)	4.2%	1.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	5.2
EV/GP/RG	11.23	0.72
Ticker research	View LNTH research	View MDLN research

Valuation

P/E Ratio

LNTH

24.56x

MDLN

44.92x

P/S Ratio

MDLN

1.59x

LNTH

4.19x

EV/FCF

LNTH

16.76x

MDLN

37.44x

Growth & revenue

Revenue Growth TTM

LNTH

2.3%

Forward Revenue Growth

LNTH

11.8%

MDLN

7.8%

Profitability & performance

Gross Margin

LNTH

61.0%

MDLN

26.2%

ROE

LNTH

23.3%

MDLN

5.5%

FCF Yield %

LNTH

5.9%

MDLN

3.2%

52-Week Performance

LNTH

87.0%

MDLN

-11.6%

Detailed metrics comparison

LNTH

Lantheus Holdings Inc

MDLN

Medline Inc

Market Cap

LNTH$6.52B

MDLN$47.63B

Enterprise Value

LNTH$6.50B

MDLN$57.88B

Price

LNTH$100.15

MDLN$36.26

P/E Ratio

LNTH24.56x

MDLN44.92x

P/S Ratio

LNTH4.19x

MDLN1.59x

EV/Sales

LNTH4.18x

MDLN1.93x

EV/EBITDA

LNTH15.80x

MDLN17.66x

P/B Ratio

LNTH4.98x

MDLN4.05x

P/FCF Ratio

LNTH16.81x

MDLN30.81x

EV/FCF

LNTH16.76x

MDLN37.44x

PEG Ratio

LNTH2.43x

MDLN3.82x

Forward P/E (NTM)

LNTH17.43x

MDLN24.12x

Forward P/S (NTM)

LNTH4.16x

MDLN1.44x

Revenue (TTM)

LNTH$1.56B

MDLN$29.94B

Revenue Growth (YoY)

LNTH2.3%

MDLNN/A

Forward Rev Growth

LNTH11.8%

MDLN7.8%

Gross Margin (TTM)

LNTH61.0%

MDLN26.2%

Operating Margin (TTM)

LNTH23.3%

MDLN6.0%

EBITDA Margin (TTM)

LNTH25.9%

MDLN10.9%

Net Margin (TTM)

LNTH17.7%

MDLN2.3%

FCF Margin (TTM)

LNTH24.9%

MDLN5.2%

Net Income (TTM)

LNTH$275M

MDLN$695M

FCF (TTM)

LNTH$388M

MDLN$1.55B

EPS (TTM)

LNTH$4.08

MDLN$0.81

ROE (TTM)

LNTH23.3%

MDLN5.5%

ROA (TTM)

LNTH11.9%

MDLN1.8%

ROIC (TTM)

LNTH15.7%

MDLN2.6%

Cash

LNTH$593M

MDLN$2.33B

Debt

LNTH$571M

MDLN$12.58B

Net Cash/Debt

LNTH$22M

MDLN$-10.25B

Current Ratio (TTM)

LNTH3.06x

MDLN4.33x

Quick Ratio (TTM)

LNTH2.89x

MDLN2.61x

Debt/Equity (TTM)

LNTH0.44x

MDLN1.09x

Debt/Assets (TTM)

LNTH0.0%

MDLN0.0%

Interest Coverage (TTM)

LNTHN/A

MDLNN/A

Net Debt/EBITDA (TTM)

LNTH0.00x

MDLN0.00x

Beta

LNTH0.04

MDLN0.94

52W Performance

LNTH87.0%

MDLN-11.6%

YTD Performance

LNTH48.9%

MDLN-10.7%

% from 52W High

LNTH-10.5%

MDLN-28.7%

% from 52W Low

LNTH99.7%

MDLN15.1%

Asset Turnover (TTM)

LNTH0.67x

MDLN0.78x

FCF Yield (TTM)

LNTH5.9%

MDLN3.2%

Earnings Yield (TTM)

LNTH4.2%

MDLN1.5%

Dividend Yield (TTM)

LNTHN/A

MDLNN/A

Rule of 40

LNTH27.3

MDLN5.2

EV/GP/RG

LNTH11.23

MDLN0.72

Ticker research

View LNTH research View MDLN research

Metric	LNTH Lantheus Holdings Inc	MDLN Medline Inc
Market & Valuation
Market Cap	$6.52B	$47.63B
Enterprise Value	$6.50B	$57.88B
Price	$100.15	$36.26
P/E Ratio	24.56x	44.92x
P/S Ratio	4.19x	1.59x
EV/Sales	4.18x	1.93x
EV/EBITDA	15.80x	17.66x
P/B Ratio	4.98x	4.05x
P/FCF Ratio	16.81x	30.81x
EV/FCF	16.76x	37.44x
PEG Ratio	2.43x	3.82x
Forward P/E (NTM)	17.43x	24.12x
Forward P/S (NTM)	4.16x	1.44x
Revenue & Growth
Revenue (TTM)	$1.56B	$29.94B
Revenue Growth (YoY)	2.3%	N/A
Forward Rev Growth	11.8%	7.8%
Profitability
Gross Margin (TTM)	61.0%	26.2%
Operating Margin (TTM)	23.3%	6.0%
EBITDA Margin (TTM)	25.9%	10.9%
Net Margin (TTM)	17.7%	2.3%
FCF Margin (TTM)	24.9%	5.2%
Net Income (TTM)	$275M	$695M
FCF (TTM)	$388M	$1.55B
EPS (TTM)	$4.08	$0.81
ROE (TTM)	23.3%	5.5%
ROA (TTM)	11.9%	1.8%
ROIC (TTM)	15.7%	2.6%
Financial Health
Cash	$593M	$2.33B
Debt	$571M	$12.58B
Net Cash/Debt	$22M	$-10.25B
Current Ratio (TTM)	3.06x	4.33x
Quick Ratio (TTM)	2.89x	2.61x
Debt/Equity (TTM)	0.44x	1.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	0.94
52W Performance	87.0%	-11.6%
YTD Performance	48.9%	-10.7%
% from 52W High	-10.5%	-28.7%
% from 52W Low	99.7%	15.1%
Efficiency & Yields
Asset Turnover (TTM)	0.67x	0.78x
FCF Yield (TTM)	5.9%	3.2%
Earnings Yield (TTM)	4.2%	1.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	5.2
EV/GP/RG	11.23	0.72
Ticker research	View LNTH research	View MDLN research